US EditionFTSE 100’s record run fades as pharma stocks slide on new Trump appointment
Summary by City AM
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
FTSE 100’s record run fades as pharma stocks slide on new Trump appointment
The FTSE 100’s record run was poised to come to an end on Wednesday as pharma stocks slumped on the back of a controversial US regulatory appointment. The blue-chip index was down 0.3 per cent in mid-morning trading. Drugmakers GSK and Astrazeneca were among the top fallers, at nearly four per cent and two per cent. This came after President Donald Trump’s Food and Drug Administration (FDA) appointed vaccine sceptic Vinay Prasad as the next di…
·London, United Kingdom
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
